Nucleic Acids Research, 2002, Vol. 30, No. 13 2972-2979
© 2002 Oxford University Press
Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter
Department of Biochemistry and Molecular Biology, Guggenheim Building 1501A, Mayo Clinic and Mayo Graduate School, 200 First Street SW, Rochester, MN 55905, USA
The ETS transcription factor family is characterized by a conserved ETS DNA-binding domain and its members have been implicated in a plethora of biological processes, including development, cell transformation and metastasis. ER71 is a testis-specific ETS protein that is not homologous to any other protein outside its ETS domain, suggesting that it fulfills a unique physiological role. Here, we report that ER71 is a constitutively nuclear protein whose intracellular localization is dependent on a portion of the ETS domain, namely ER71 amino acids 276–315. Furthermore, the DNA binding activity is intramolecularly regulated, as the N-terminus of ER71 has a negative effect on DNA binding while the C-terminus dramatically enhances this activity. We also demonstrate that ER71 possesses an extremely potent N-terminal transactivation domain comprised of amino acids 1–157. Finally, we show that ER71 is capable of directly activating both an E74 site-driven and the matrix metalloproteinase-1 promoter. Altogether, these data represent the first functional characterization of ER71, which may perform important functions in the developing and adult testis as well as in testicular germ cell tumorigenesis.
* To whom correspondence should be addressed. Tel: +1 507 266 4393; Fax: +1 507 284 1767; Email: janknecht.ralf{at}mayo.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Shin, T.-D. Kim, F. Jin, J. M. van Deursen, S. M. Dehm, D. J. Tindall, J. P. Grande, J.-M. Munz, G. Vasmatzis, and R. Janknecht Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81 Cancer Res., October 15, 2009; 69(20): 8102 - 8110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sumanas, G. Gomez, Y. Zhao, C. Park, K. Choi, and S. Lin Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation Blood, May 1, 2008; 111(9): 4500 - 4510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shin, K. L. Rossow, J. P. Grande, and R. Janknecht Involvement of RNA Helicases p68 and p72 in Colon Cancer Cancer Res., August 15, 2007; 67(16): 7572 - 7578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kopp, P. J. Wilder, M. Desler, L. Kinarsky, and A. Rizzino Different Domains of the Transcription Factor ELF3 Are Required in a Promoter-specific Manner and Multiple Domains Control Its Binding to DNA J. Biol. Chem., February 2, 2007; 282(5): 3027 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Prescott, K. S. N. Koto, M. Singh, and A. Gutierrez-Hartmann The ETS Transcription Factor ESE-1 Transforms MCF-12A Human Mammary Epithelial Cells via a Novel Cytoplasmic Mechanism Mol. Cell. Biol., June 15, 2004; 24(12): 5548 - 5564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goel and R. Janknecht Concerted Activation of ETS Protein ER81 by p160 Coactivators, the Acetyltransferase p300 and the Receptor Tyrosine Kinase HER2/Neu J. Biol. Chem., April 9, 2004; 279(15): 14909 - 14916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Goueli and R. Janknecht Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf Mol. Cell. Biol., January 1, 2004; 24(1): 25 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Dowdy, A. Mariani, and R. Janknecht HER2/Neu- and TAK1-mediated Up-regulation of the Transforming Growth Factor {beta} Inhibitor Smad7 via the ETS Protein ER81 J. Biol. Chem., November 7, 2003; 278(45): 44377 - 44384. [Abstract] [Full Text] [PDF]
|
|